1. Introduction {#sec1-molecules-25-00462}
===============

*Elaeagnus angustifolia* L., commonly called oleaster or Russian olive, is a medicinal plant belonging to the Elaeagnacea family. It is widely distributed from the northern regions of Asia to the Himalayas and Europe \[[@B1-molecules-25-00462]\]. *E. angustifolia* is mainly planted in various provinces of Northwest of China, for wind breaks and sand fixation \[[@B2-molecules-25-00462]\]. The flowers of *E. angustifolia* were traditionally used to treat asthma and tetanus in Iran and China \[[@B3-molecules-25-00462],[@B4-molecules-25-00462],[@B5-molecules-25-00462]\]. In Chinese Uygur medicine, *E. angustifolia* flowers were considered as dry and hot materials, which is mainly used to treat brain disease, thoracalgia and asthma in the clinic. According to the specialists in traditional medicine, *E. angustifolia* flowers are a herbal medication which can stimulate sexuality, especially in young girls and women \[[@B6-molecules-25-00462]\]. Zeinalzadeh et al. reported a randomized clinical trial to compare the effect of *E. angustifolia* flower capsule and sildenafil citrate tablet on sexual interest/arousal disorder \[[@B7-molecules-25-00462]\]. Previous phytochemical investigations of *E. angustifolia* flowers focused on the essential oil and the total flavonoids content, and few studies were conducted on the isolation and identification of compounds present in the flowers \[[@B8-molecules-25-00462],[@B9-molecules-25-00462],[@B10-molecules-25-00462]\]. Our group previously reported the identification of a novel macrocyclic flavonoid glycoside from the flowers of this plant \[[@B11-molecules-25-00462]\]. In continuation of this program, a new triterpenoid saponin (**1**), and two new lignan glucosides (**2** and **3**) ([Figure 1](#molecules-25-00462-f001){ref-type="fig"} and [Supplementary Materials](#app1-molecules-25-00462){ref-type="app"}), were further isolated and identified from *E. angustifolia* flowers. Herein, the isolation, structural elucidation, and cytotoxic activities of the compounds, were presented.

2. Results and Discussion {#sec2-molecules-25-00462}
=========================

Compound **1** was isolated as white powder; its molecular formula was identified as C~69~H~110~O~29~ by the pseudomolecular ion peak at *m*/*z* 1447.6933 \[M + HCOO\]^-^ (calcd for C~70~H~111~O~31~, 1447.7109) in the HRESIMS spectrum. The ^1^H-NMR spectrum of **1** ([Table 1](#molecules-25-00462-t001){ref-type="table"}) showed signals for nine tertiary methyl groups at *δ*~H~ 1.81, 1.27, 1.17, 1.04, 1.03, 0.95, 0.90, 0.86, and 0.79 (each 3H, s), a secondary methyl at *δ*~H~ 1.21 (3H, d, *J* = 6.2 Hz), several anomeric protons and olefinic protons signals at *δ*~H~ 4.30--6.00, as well as many sugar moiety protons signals at *δ*~H~ 3.00--4.10. The ^13^C NMR spectrum (with HSQC experiments, [Table 1](#molecules-25-00462-t001){ref-type="table"}) revealed the presence of 69 carbon resonances including five anomeric carbons (*δ*~C~ 106.2, 105.9, 103.5, 101.3 and 95.9), and two ester carbonyls (*δ*~C~ 176.3 and 169.3). The above-mentioned data was typical for triterpenoid saponin, and the olefinic proton signal at *δ*~H~ 5.30 (1H, t, *J* = 3.3 Hz, H-12) implied that it is an oleanolic-type saponin \[[@B12-molecules-25-00462]\].

Acid hydrolysis of compound **1** yielded xylose, glucose and rhamnose, their configurations were identified as [d]{.smallcaps}-configuration for xylose and glucose, and [l]{.smallcaps}-configuration for rhamnose by the method gave in the experiment part. Analysis of HSQC, HMQC-TOCSY, and ^1^H-^1^H COSY spectrum clarified the proton and carbon signals of five sugar units (a xylose, three glucoses and a rhamnose) as shown in [Table 1](#molecules-25-00462-t001){ref-type="table"}. Aside from the signals for the sugar units, 40 other carbon signals were observed in the ^13^C-NMR spectrum. Further analysis of 2D NMR data revealed the presence of an aglycone with 3,21-dihydroxyolean-12-en-28-oic acid skeleton. There are 10 carbon signals remaining except the five sugar units and 3,21-dihydroxyolean-12-en-28-oic acid skeleton.

The ^1^H-^1^H COSY correlations ([Figure 2](#molecules-25-00462-f002){ref-type="fig"}a) of H-3′/H-4′/H-5′ and H-7′/H-8′, and the HMBC correlations ([Figure 2](#molecules-25-00462-f002){ref-type="fig"}a) from H~3~-9′ to C-1′ (*δ*~C~ 169.3), C-2′ (*δ*~C~ 129.0) and C-3′ (*δ*~C~ 144.3); from H~3~-10′ to C-5′ (*δ*~C~ 41.7), C-6′ (*δ*~C~ 73.7) and C-7′ (*δ*~C~ 146.1), indicated the presence of a 6-hydroxy-2,6-dimethyl-octa-2,7-dienoyl monoterpene moiety. Thus, the three units (sugars, triterpenoid and monoterpene) of **1** were determined, and their connections are the next thing to solve. The HMBC correlation from H-1′′ to C-3 (*δ*~C~ 90.0) connected the xylose to C-3. A rhamnose and glucose were linked to positions 2 and 3 of xylose, respectively, by the HMBC correlations ([Figure 2](#molecules-25-00462-f002){ref-type="fig"}a) from H-1′′′ to C-2′′ (*δ*~C~ 75.5) and from H-1′′′′ to C-3′′ (*δ*~C~ 83.2). The HMBC correlation from H-1′′′′′ to C-2′′′′ (*δ*~C~ 83.9) assigned another glucose to position 2 of the glucose connected to xylose. The last glucose was connected to C-28 on the basis of the HMBC correlation from H-1′′′′′′ to C-28 (*δ*~C~ 176.3). Compared the CH-21 (*δ*~H~ 4.81, *δ*~C~ 77.0) chemical shift of **1** to that of known compound machaerinic acid \[[@B13-molecules-25-00462]\], obvious down-field shift indicated the monoterpene moiety was attached to C-21, although the HMBC correlation from H-21 to C-1′ was not observed. The NOESY correlations ([Figure 2](#molecules-25-00462-f002){ref-type="fig"}b): from H-3 to H-5, from H-5 to H-9, from H-9 to H~3~-27, from H~3~-27 to H-16α, from H-16α to H-21, and from H-21 to H~3~-29, indicated they were in the same face. Correspondingly, the NOESY correlations from H~3~-24 to H~3~-25, from H~3~-25 to H~3~-26, and from H-18 to H~3~-30, revealed they took β-orientation. The *Z*-geometry of Δ^2′^ was determined by the NOESY correlation between H-3′ and H~3~-9′. Therefore, the structure of compound **1** was elucidated as shown in [Figure 1](#molecules-25-00462-f001){ref-type="fig"}, and it was given the trivial name terpengustifol A.

Compounds **2** and **3** were obtained originally as a mixture as they were showed as one peak in the HPLC chromatography using a reverse phase C~18~ column. The ^1^H-NMR spectrum of the mixture cannot distinguish they are two compounds, while there are some subtle differences of several carbon resonances in the ^13^C-NMR spectrum. Chiral chromatography analysis of the mixture showed that there were two peaks with a ratio around 1:1. Thus, compounds **2** and **3** were separated by chiral chromatography. The molecular formula of compounds **2** and **3** were established as C~26~H~34~O~10~ by their HRESIMS data (*m*/*z* 551.2091 and 551.2086 \[M + HCOO\]^−^; calcd for C~27~H~35~O~12~, 551.2129). In the ^1^H- NMR spectrum ([Table 2](#molecules-25-00462-t002){ref-type="table"}) of **2**, the signals for two 1,3,4-trisubstituted aromatic rings \[*δ*~H~ 7.15 (1H, d, *J* = 8.3 Hz, H-5), 7.11 (1H, d, *J* = 1.8 Hz, H-2), 6.97 (1H, dd, *J* = 8.3, 1.8 Hz, H-6); 6.98 (1H, d, *J* = 1.9 Hz, H-2′), 6.90 (1H, d, *J* = 8.3 Hz, H-5′), 6.84 (1H, dd, *J* = 8.3, 1.9 Hz, H-6′)\], a *trans* double bond signals \[*δ*~H~ 6.33 (1H, dd, *J* = 15.7, 1.6 Hz, H-7′), 6.15 (1H, dq, *J* = 15.7, 6.5 Hz, H-8′)\], two oxygenated methines \[*δ*~H~ 4.70 (1H, d, *J* = 6.1 Hz, H-7), 4.43 (1H, dq, *J* = 6.2, 6.1 Hz, H-8)\], a series of proton signals fa or sugar moiety at *δ*~H~ 3.00--5.00, two methoxy groups signals (*δ*~H~ 3.87, 3.85, each 3H, s), and two methyl signals \[*δ*~H~ 1.85 (3H, dd, *J* = 6.5, 1.6 Hz, H-9′), 1.08 (3H, d, *J* = 6.2 Hz, H-9)\], were observed. The anomeric proton resonated at *δ*~H~ 4.88 (1H, d, *J* = 7.5 Hz, H-1′′) suggested it is in a β-configuration. The ^13^C-NMR and HSQC spectrum of **2** showed 26 carbon resonances, corresponding to four methyls, one methylene, 15 methines (including eight sp^2^ carbons), and six quaternary carbons. In addition to the sugar moiety and two methoxy groups, the remaining 18 carbons suggested that compound **2** is likely a lignan glycoside.

Further analysis of 2D NMR data (^1^H-^1^H COSY, HSQC, HMBC) of **2** established the planar structure. A hexose moiety (C-1′′ to C-6′′) and two subunits (C-7 to C-9 and C-7′ to C-9′) (drawn with bold bond in [Figure 3](#molecules-25-00462-f003){ref-type="fig"}) were established based on the ^1^H--^1^H COSY correlations. The three fragments were connected to the other functional groups by the HMBC correlations ([Figure 3](#molecules-25-00462-f003){ref-type="fig"}). The linkage between C-7 and C-1 was determined by the HMBC correlations from H-7 to C-1, C-2 and C-6, and the linkage between C-8 and C-4′ via ether bond by the HMBC correlations from H-8 to C-4′. The fragment C-7′ to C-9′ was linked to C-1′ by the HMBC correlation from H-7′ to C-2′ and C-6′.

The HMBC correlation from H-1′′ to C-4 indicated the hexose moiety was connected to C-4. Thus, the planar structure of **2** was elucidated as depicted.

Compound **3** had the same planar structure as **2** based on analysis of the NMR data. Both compounds **2** and **3** produced [d]{.smallcaps}-glucose after acid hydrolysis, indicating that the difference between them was the stereochemistry of C-7 and C-8. The large coupling constant between H-7 and H-8 (*J* = 6.1 Hz) of compounds **2** and **3** indicated they had the same 7,8-*threo* configuration \[[@B14-molecules-25-00462]\]. Therefore, compounds **2** and **3** are a pair of diastereoisomers, making their aglycones a pair of enantiomers. An ECD calculation was applied to elucidate the absolute configurations of C-7 and C-8. Due to the excessive number of chiral centers of glucose, a model compound **4** ([Figure 4](#molecules-25-00462-f004){ref-type="fig"}a) was selected to simplify the calculation. As shown in the [Figure 4](#molecules-25-00462-f004){ref-type="fig"}b, the calculated ECD of (7*R*,8*R*)-**4** showed a similar Cotton effect as compound **3**, which indicated that compound **3** had a 7*R*,8*R*-configuration. Correspondingly, compound **2** possesses a 7*S*,8*S* configuration. Thus, the structures of compounds **2** and **3** were determined as shown in [Figure 1](#molecules-25-00462-f001){ref-type="fig"}, and they were given the trivial names phengustifol A and B, respectively.

There are many reports about the cytotoxicity of triterpenoid saponins and lignan glucosides against various cell lines \[[@B15-molecules-25-00462],[@B16-molecules-25-00462],[@B17-molecules-25-00462],[@B18-molecules-25-00462]\], thus, the three new compounds obtained in the current study were tested for cytotoxic activity against the A375 human melanoma cell line using the CCK8 method \[[@B19-molecules-25-00462]\]. The results revealed that compounds **1** and **2** exhibited moderate cytotoxic activities, with IC~50~ values at 12.1 and 15.6 μM, respectively, while compound **3** showed weak cytotoxicity with an IC~50~ value of 62.8 μM. The IC~50~ value for the positive control cabazitaxel was 0.11 μM.

3. Materials and Methods {#sec3-molecules-25-00462}
========================

3.1. General Procedures {#sec3dot1-molecules-25-00462}
-----------------------

UV spectra were measured on a UV-2550 UV-visible spectrophotometer (Shimadzu, Shimane-ken, Japan). IR spectra were recorded on a 380 FT-IR spectrometer (Thermo Nicolet, Waltham, MA, USA). The optical rotations were measured on an AutoPol IV automatic polarimeter (Rudolph Research, Wilmington, MA, USA) at room temperature. 1D and 2D NMR data were recorded on a 600 MHz instrument (Varian, Palo Alto, CA, USA) with TMS as internal standard. HRESIMS data were acquired using a Triple TOF 6600 mass spectrometer (AB Sciex, Framingham, MA, USA). Semi-preparative HPLC separations were performed on a Chromaster system (Hitachi, Tokyo, Japan) consisting of a 5110 pump, 5210 autosampler, 5310 column oven, 5430 diode array detector and a Phenomenex Luna C~18~ column (250 × 10 mm, S-5 μm), all operated using EZChrom Elite software. All solvents were of ACS or HPLC grade, and were obtained from Tansoole (Shanghai, China) and Sigma-Aldrich (St. Louis, MO, USA), respectively. Silica gel (300--400 mesh), C~18~ reverse-phased silica gel (150-200 mesh, Merck, Darmstadt, German), and MCI gel (CHP20P, 75--150 μM, Mitsubishi Chemical Industries Ltd., Tokyo, Japan) were used for column chromatography (CC), and pre-coated silica gel GF254 plates (Qingdao Marine Chemical Plant, Qingdao, China) were used for TLC.

3.2. Plant Material {#sec3dot2-molecules-25-00462}
-------------------

*Elaeagnus angustifolia* flowers were collected from Changji (Xinjiang Province, China) and identified by Prof. Yan Wei (College of Grassland and Environment Sciences, Xinjiang Agricultural University). A voucher specimen (EA-201506) is deposited in the Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (Xinjiang, China).

3.3. Extraction and Isolation {#sec3dot3-molecules-25-00462}
-----------------------------

Air-dried ground powder of *E. angustifolia* flowers (1.0 kg) was sequentially extracted with petroleum ether (8 L × 3) and methanol (10 L × 3) by maceration at room temperature (7 days each time) to afford a crude methanol extract. The crude methanol extract was suspended in distilled water and then extracted successively with petroleum ether (PE), ethyl acetate and *n*-butanol. The *n*-butanol fraction (69.2 g) was subjected to a column of MCI gel (MeOH-H~2~O, 10:90 to 100:0, *v*/*v*) to yield six fractions (A-F). Fraction F (3.5 g) was subjected to a C18 reverse-phased silica gel column eluting with step gradient MeOH-H~2~O (30:70 to 60:40, *v*/*v*) to give 12 fractions F1-F12. Fraction F5 (300.0 mg) was separated on Sephadex LH-20 column eluted with MeOH to yield 11 sub-fractions F5a--F5k. Sub-fraction F5e (36.4 mg) was purified by semi-preparative HPLC, eluting with isocratic MeOH-H~2~O (57:43, *v*/*v*, 3 mL/min) to yield the mixture of compounds **2** and **3**. The mixture was then separated on chiral column (CHIRALPAK^®^ AD-H, 10 × 250 mm, 5 μm, Daicel Chiral) eluting with n-hexane/isopropanol (70/30, *v*/*v*) at 3 mL/min flow rate to get compounds **2** (2.4 mg) and **3** (2.2 mg). Fraction F9 (105.0 mg) was subjected to a Sephadex LH-20 column eluted with MeOH to yield eight sub-fractions F9a--F9h. Purification of F9b (36.9 mg) using semi-preparative HPLC eluted with MeOH/H~2~O (70/30 to 80/20 in 30 min, 3mL/min) to yield compound **1** (6.4 mg).

*Terpengustifol A* (**1**): white amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ = +44 (*c* 0.200, MeOH); UV (MeOH) *λ*~max~: 202, 220 nm; IR ν~max~ 3422, 2926, 1685, 1676, 1610, 1437, 1388, 1076, 1018 cm^−1^; ^1^H-NMR and ^13^C-NMR data, see [Table 1](#molecules-25-00462-t001){ref-type="table"}; HR-ESI-MS: *m/z* 1447.6933 \[M + HCOO\]^−^ (calcd for C~70~H~111~O~31~, 1447.7109).

*Phengustifol A* (**2**): white amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ = −48 (*c* 0.05, MeOH); UV (MeOH) *λ*~max~: 204, 260 nm; IR ν~max~ 3427, 2921, 1682, 1508, 1456, 1264, 1031, 801 cm^−1^; ^1^H-NMR and ^13^C-NMR data, see [Table 2](#molecules-25-00462-t002){ref-type="table"}; HR-ESI-MS: *m/z* 551.2091 \[M + HCOO\]^−^ (calcd for C~27~H~35~O~12~, 551.2129).

*Phengustifol B* (**3**): white amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ = −12 (*c* 0.05, MeOH); UV (MeOH) *λ*~max~: 204, 260 nm; ^1^H-NMR and ^13^C-NMR data, see [Table 2](#molecules-25-00462-t002){ref-type="table"}; HR-ESI-MS: *m/z* 551.2086 \[M + HCOO\]^−^ (calcd for C~27~H~35~O~12~, 551.2129).

3.4. Acid Hydrolysis of Compounds **1**-**3** and Sugar Analysis {#sec3dot4-molecules-25-00462}
----------------------------------------------------------------

Each compound (1.0 mg) was added to 1 mL HCl (1 N) and refluxed for 2 h. The solution was evaporated under a stream of N~2~ after cooling. Mixture of the residue, anhydrous pyridine solution (0.1 mL) and [l]{.smallcaps}-cysteine methyl ester hydrochloride (0.06 N) was heated at 60 °C for half an hour. Removing the solvent, the residue was partitioned between water and cyclohexane. The cyclohexane layer was dried and dissolved in 200 μL acetone for GC analysis.

3.5. Cytotoxicity Assay {#sec3dot5-molecules-25-00462}
-----------------------

The Cell Counting Kit 8 (CCK-8) assay was used to evaluate the cytotoxicity of the compounds against A375 cells. The cells were cultured in DMEM with 10% FBS in a humidified incubator with 5% CO~2~ at 37 °C for 24 h. The test compounds and positive control were added to the cultures and incubated for another 24 h. After that, the supernatant was removed, 10 μL of CCK8 (Dojindo, Kumamoto, Japan) reagent was added per well and incubated at 37 °C for 2 h. The samples were then transferred to a microplate reader to measure the optical density at a wavelength of 450 nm. Cabazitaxel was used as positive control.

4. Conclusions {#sec4-molecules-25-00462}
==============

In the present work, three new compounds **1**--**3**, including a triterpenoid saponin and two lignan glucosides, were isolated and identified from *Elaeagnus angustifolia* flowers. Compound **1** possesses an unusual (*Z*)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl monoterpene unit at C-21. Compounds **2** and **3** are a pair of diastereoisomers, while their aglycones are a pair of enantiomers. The bioassay indicated that all of the compounds showed somehow cytotoxic activities against A375, compounds **1** and **2** exhibited moderate activities. Interestingly, compound **2** showed stronger cytotoxic activities than that of **3** due to the different absolute configurations of their aglycones.
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![Chemical structures of compounds **1**--**3**.](molecules-25-00462-g001){#molecules-25-00462-f001}

![(**a**) Key ^1^H-^1^H COSY (−) and selected HMBC correlations (H→C) of **1**; (**b**) Key NOESY (↔) correlations of **1**.](molecules-25-00462-g002){#molecules-25-00462-f002}

![Key ^1^H-^1^H COSY (−) and selected HMBC correlations (H→C) of **2**.](molecules-25-00462-g003){#molecules-25-00462-f003}

![(**a**) Chemical structure of model compound **4**; (**b**) Experimental ECD spectra of **2** and **3**, and calculated ECD spectra for **4**.](molecules-25-00462-g004){#molecules-25-00462-f004}

molecules-25-00462-t001_Table 1

###### 

^1^H- and ^13^C-NMR spectroscopic data of **1**^*a*^ (in CD~3~OD).

  Genin part   *δ*~H~ (Mult; *J*, Hz)           *δ* ~C~   Sugar Part                *δ*~H~ (Mult; *J*, Hz)   *δ* ~C~
  ------------ -------------------------------- --------- ------------------------- ------------------------ ---------
  1            1.60 (m), 0.96 (m)               40.4      Xyl (C-3)                                          
  2            1.84 (m), 1.68 (m)               27.4      1′′                       4.36 (d, 6.7)            106.2
  3            3.13 (dd, 11.6, 4.0)             90.0      2′′                       3.88 (m)                 75.5
  4                                             40.5      3′′                       3.85 (m)                 83.2
  5            0.77 (brd, 11.3)                 57.6      4′′                       4.04 (m)                 70.8
  6            1.53 (m), 1.39 (m)               19.5      5′′                       3.83 (m), 3.53 (m)       66.7
  7            1.47 (m), 1.31 (m)               34.1      Rha-(1→2)-Xyl                                      
  8                                             40.9      1′′′                      5.58 (brs)               101.3
  9            1.57 (m)                         49.1      2′′′                      3.91 (m)                 72.4
  10                                            38.1      3′′′                      3.69 (m)                 72.3
  11           2.24 (m), 1.91 (m)               24.7      4′′′                      3.40 (m)                 74.0
  12           5.30 (t, 3.3)                    124.7     5′′′                      4.06 (m)                 70.1
  13                                            143.6     6′′′                      1.21 (3H, d, 6.2)        18.0
  14                                            43.1      Glc-(1→3)-Xyl                                      
  15           1.75 (m), 1.11 (brd, 14.2)       29.1      1′′′′                     4.64 (d, 7.1)            103.5
  16           2.12 (td, 14.2, 3.3), 1.91 (m)   25.3      2′′′′                     3.59 (m)                 83.9
  17                                            49.4      3′′′′                     3.36 (m)                 78.2
  18           2.93 (dd, 13.7, 4.0)             42.2      4′′′′                     3.35 (m)                 71.3
  19           1.92 (m), 1.31 (m)               47.7      5′′′′                     3.58 (m)                 78.4
  20                                            36.4      6′′′′                     3.84 (m), 3.66 (m)       62.6
  21           4.81 (dd, 11.9, 4.7)             77.0      Glc-(1→2)-Glc-(1→3)-Xyl                            
  22           1.86 (m), 1.65 (m)               37.2      1′′′′′                    4.74 (d, 7.2)            105.9
  23           1.03 (3H, s)                     28.7      2′′′′′                    3.36 (m)                 76.0
  24           0.86 (3H, s)                     17.5      3′′′′′                    3.29 (m)                 78.7
  25           0.95 (3H, s)                     16.3      4′′′′′                    3.35 (m)                 71.0
  26           0.79 (3H, s)                     17.8      5′′′′′                    3.36 (m)                 78.1
  27           1.17 (3H, s)                     26.3      6′′′′′                    3.89 (m), 3.71 (m)       62.3
  28                                            176.3     Glc (C-28)                                         
  29           0.90 (3H, s)                     29.3      1′′′′′′                   5.38 (d, 8.2)            95.9
  30           1.04 (3H, s)                     18.9      2′′′′′′                   3.30 (m)                 74.0
  1′                                            169.3     3′′′′′′                   3.33 (m)                 78.9
  2′                                            129.0     4′′′′′′                   3.35 (m)                 71.1
  3′           6.76 (td, 7.6, 1.2)              144.3     5′′′′′′                   3.58 (m)                 78.4
  4′           2.24 (m), 1.83 (m)               24.4      6′′′′′′                   3.80 (m), 3.67 (m)       62.4
  5′           1.60 (2H, m)                     41.7                                                         
  6′                                            73.7                                                         
  7′           5.91 (dd, 17.4, 10.8)            146.1                                                        
  8′           5.22 (dd, 17.4, 1.4)             112.6                                                        
               5.05 (dd, 10.8, 1.4)                                                                          
  9′           1.81 (3H, s)                     12.6                                                         
  10′          1.27 (3H, s)                     28.0                                                         

*^a^* Recorded at 600 or 150 MHz for ^1^H and ^13^C, respectively.

molecules-25-00462-t002_Table 2

###### 

^1^H- and ^13^C- NMR spectroscopic data of compounds **2**--**3***^a^* (in CD~3~OD).

  Position   2                      3                               
  ---------- ---------------------- -------- ---------------------- --------
  1                                 137.41                          137.39
  2          7.11 (d, 1.8)          112.92   7.11 (d, 1.9)          112.85
  3                                 150.70                          150.73
  4                                 147.70                          147.69
  5          7.15 (d, 8.3)          117.66   7.15 (d, 8.3)          117.66
  6          6.97 (dd, 8.3, 1.8)    121.19   6.96 (dd, 8.3, 1.9)    121.24
  7          4.70 (d, 6.1)          77.87    4.70 (d, 6.1)          77.83
  8          4.43 (dq, 6.2, 6.1)    81.55    4.43 (dq, 6.2, 6.1)    81.54
  9          1.08 (d, 6.2)          16.53    1.09 (d, 6.3)          16.53
  1′                                134.07                          134.07
  2′         6.98 (d, 1.9)          111.10   6.99 (d, 1.9)          111.10
  3′                                151.96                          151.96
  4′                                147.94                          147.94
  5′         6.90 (d, 8.3)          118.26   6.91 (d, 8.3)          118.25
  6′         6.84 (dd, 8.3, 1.9)    120.13   6.84 (dd, 8.3, 1.9)    120.14
  7′         6.33 (dd, 15.7, 1.6)   132.05   6.34 (dd, 15.7, 1.6)   132.05
  8′         6.15 (dq, 15.7, 6.5)   125.02   6.15 (dq, 15.7, 6.6)   125.02
  9′         1.85 (dd, 6.5, 1.6)    18.65    1.85 (dd, 6.6, 1.6)    18.65
  3-OMe      3.87 (3H, s)           56.86    3.87 (3H, s)           56.86
  3′-OMe     3.85 (3H, s)           56.66    3.85 (3H, s)           56.66
  Glu                                                               
  1          4.88 (d, 7.5)          103.03   4.89 (d, 7.4)          103.00
  2          3.48 (dd, 9.1, 7.5)    75.08    3.49 (dd, 9.1, 7.4)    75.08
  3          3.45 (dd, 9.1, 8.5)    78.00    3.46 (dd, 9.1, 8.3)    78.01
  4          3.40 (m)               71.51    3.40 (m)               71.51
  5          3.40 (m)               78.36    3.40 (m)               78.37
  6          3.86 (m)               62.67    3.86 (m)               62.67
             3.70 (dd, 12.1, 5.1)            3.69 (dd, 12.0, 5.1)   

*^a^* Recorded at 600 or 150 MHz for ^1^H and ^13^C, respectively.

[^1]: These authors contributed equally to this work.
